Still suffering from the loss of patent protection on its big Alzheimer’s drug Aricept, Japan’s Eisai said today that the company had fired off a pair of applications for its new cancer drug to U.S. as well as European regulators.

…read more

Source: Struggling Eisai files its thyroid cancer drug lenvatinib in U.S., EU


0 No comments